SAW
BMY icon

Signal Advisors Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Signal Advisors Wealth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$476K Buy
7,852
+539
+7% +$31.4K 0.03% 373
2025
Q4 		$394K Sell
7,313
-4,668
-39% -$225K 0.03% 353
2025
Q3 		$540K Sell
11,981
-17,177
-59% -$802K 0.05% 258
2025
Q2 		$1.35M Buy
+29,158
New +$1.43M 0.11% 179

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Signal Advisors Wealth's BMY Position: Q1 2026 in Review

Signal Advisors Wealth increased its Bristol-Myers Squibb (BMY) stake by 7.4% in Q1 2026, buying an estimated $31.4K and bringing the position to 7,852 shares worth $476K. The position accounts for 0.03% of the portfolio, ranked #373.

Signal Advisors Wealth first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.35M in Q2 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Signal Advisors Wealth held 7,852 shares of Bristol-Myers Squibb worth $476K as of Q1 2026.
  • Signal Advisors Wealth bought 539 Bristol-Myers Squibb shares in Q1 2026, an estimated $31.4K.
  • Bristol-Myers Squibb made up 0.03% of Signal Advisors Wealth's portfolio in Q1 2026, its #373 holding.
  • Signal Advisors Wealth first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
  • Signal Advisors Wealth's Bristol-Myers Squibb position peaked at $1.35M in Q2 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Signal Advisors Wealth's 13F filing for Q1 2026, filed 17 Apr 2026.